Home / Import refusals / SCS-0689980-3/11/2

FDA Import Refusal SCS-0689980-3/11/2 — LGM Pharma LLC

LGM Pharma LLC — FEI 3012048333

The FDA refused shipment SCS-0689980-3/11/2 from LGM Pharma LLC (United States) on July 20, 2020. The refused product falls under Drugs and Biologics — DICLOFENAC SODIUM (ANTI-INFLAMMATORY). Cited charge: 118 This firm has 1 other import refusal on record.

Refusal Details

Date
July 20, 2020
Country
United States
Product Category
Drugs and Biologics
Product Code
62GDO18 DICLOFENAC SODIUM (ANTI-INFLAMMATORY)
Charges
118

Recent inspections

  • 1242488 (VAI Fri Jun 28 2024 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1166776 (OAI Fri Apr 08 2022 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1073414 (OAI Tue Dec 04 2018 00:00:00 GMT+0000 (Coordinated Universal Time))

Compliance actions

  • Injunction (379) (Mon Jan 30 2023 00:00:00 GMT+0000 (Coordinated Universal Time))

Other import refusals

  • SCS-6178924-8/41/1 (Thu Oct 03 2024 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)

FDA data resources